MegaPro Biomedical Co., Ltd
MegaPro Biomedical Co., Ltd, a biotech company, focuses on the development of nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma; and MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia, as well as MPB-1734, an anti-cancer drug that is in precl… Read more
Market Cap & Net Worth: MegaPro Biomedical Co., Ltd (6827)
MegaPro Biomedical Co., Ltd (TWO:6827) has a market capitalization of $26.05 Million (NT$861.84 Million) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #46653 globally and #2055 in its home market, demonstrating a -3.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MegaPro Biomedical Co., Ltd's stock price NT$10.85 by its total outstanding shares 79431903 (79.43 Million).
MegaPro Biomedical Co., Ltd Market Cap History: 2026 to 2026
MegaPro Biomedical Co., Ltd's market capitalization history from 2026 to 2026. Data shows growth from $26.05 Million to $26.05 Million (0.00% CAGR).
MegaPro Biomedical Co., Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MegaPro Biomedical Co., Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6827 by Market Capitalization
Companies near MegaPro Biomedical Co., Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to MegaPro Biomedical Co., Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
MegaPro Biomedical Co., Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, MegaPro Biomedical Co., Ltd's market cap moved from $26.05 Million to $ 26.05 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$26.05 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MegaPro Biomedical Co., Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.05 Million USD |
| MoneyControl | $26.05 Million USD |
| MarketWatch | $26.05 Million USD |
| marketcap.company | $26.05 Million USD |
| Reuters | $26.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.